No major role of norepinephrine transporter gene variations in the cardiostimulant effects of MDMA.

Patrick VizeliHenriette E Meyer Zu SchwabedissenMatthias E Liechti

Published in: European journal of clinical pharmacology (2017)

Genetic polymorphisms of the SLC6A2 gene weakly moderated the acute cardiovascular response to MDMA in controlled studies and may play a minor role in adverse cardiovascular events when MDMA is used recreationally.

Keyphrases

cardiovascular events
coronary artery disease
copy number
genome wide
cardiovascular disease
liver failure
genome wide identification
respiratory failure
dna methylation
type diabetes
gene expression
transcription factor
intensive care unit
case control